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Abstract Tick-borne diseases are a potential threat that
account for significant morbidity and mortality in human
population worldwide. Vaccines are not available to treat
several of the tick-borne diseases. With the emergence and
resurgence of several tick-borne diseases, emphasis on the
development of transmission-blocking vaccines remains
increasing. In this review, we provide a snap shot on some
of the potential candidates for the development of anti-
vector vaccines (a form of transmission-blocking vaccines)
against wide range of hard and soft ticks that include
Ixodes, Haemaphysalis, Dermacentor, Amblyomma, Rhi-
picephalus and Ornithodoros species.
Keywords Transmission-blocking vaccine 
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Introduction
Arthropod-borne diseases account for severe morbidity and
mortality in worldwide human population (Githeko et al.
2000; Hill et al. 2005). Based on the disability-adjusted life
year (DALY) estimates, infections associated with one-
sixth of the human population are due to arthropod-borne
diseases (Hill et al. 2005; WHO 2004). World Health
Organization (WHO) reports malaria to be the leading
vector-borne disease in the world followed by
Leishmaniasis, Trypanosomiasis, Yellow fever, Dengue,
Chagas disease and Japanese Encephalitis (Hill et al. 2005;
WHO 2004, 2013, 2014). The recent epidemics of histor-
ically recognized diseases such as Tick-borne encephalitis,
Kyasanur forest disease, Crimean-Congo hemorrhagic
fever and Rocky mountain spotted fever suggests increase
in the scope and magnitude of tick-borne diseases world
wide (Demma et al. 2006; Maltezou et al. 2010; Pattnaik
2006; Randolph 2008). Even though tick-borne diseases
are considered pale in comparison to the other arthropod-
borne diseases, the steady increase in the annual incidence
of some of the tick-borne diseases such as Lyme disease,
human anaplasmosis and human monocytic ehrlichiosis
implies a potential threat to human health (CDC 2014).
Some of the important tick-borne diseases that occur
worldwide are listed in Table 1. No vaccines or effective
therapies are available to treat several of these important
vector-borne diseases.
There are about 5–19 million species of arthropods
existing in the world of which some serve as vectors for
various pathogens that cause diseases in humans (Ødegaard
2000). Arthropods have become most successful to serve as
competent vectors for disease transmission due to their
capacity of biting host, ingesting blood meal from hosts
and permitting pathogen survival in them for a longer
period of time (Desenclos 2011; Goddard 2008). Several
studies have reported use of live-attenuated parasite vac-
cine candidates to control arthropod-borne disease
pathogenesis in various animal models (Barry et al. 2009;
Callow 1978; Conlan 2011; Gardner and Ryman 2010;
Heinz and Stiasny 2012; Orlinger et al. 2011; Reed et al.
2014; Sultana et al. 2009; Wang et al. 2014a; Yun and Lee
2014). However, limited of them are successful and
approved for human use (Conlan 2011; Gardner and
Ryman 2010; Orlinger et al. 2011; Yun and Lee 2014).
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Therefore, effective strategies need to be developed in
order to combat both arthropods and pathogens. Of many
strategies (Coutinho-Abreu et al. 2009; Oliveira et al. 2009;
Thomas and Read 2007; Valenzuela 2004a, b), develop-
ment of transmission-blocking vaccines has provided a
significant leap that has moved research in this field for-
ward for clinical trials (Malkin et al. 2005; Saul et al. 2007;
Wu et al. 2008).
Anti-vector vaccines are a type of transmission-blocking
vaccines aimed to target vector molecules to block pathogen
Table 1 Worldwide tick-borne
diseases
Tick-borne diseases Agent Tick species Tick family
Lyme Borreliosis Borrelia burgdorferi Ixodes scapularis Ixodidae
I. dentatus Ixodidae
I. pacificus Ixodidae
B. afzelii I. ricinus Ixodidae
I. persulcatus Ixodidae
I. nipponensis Ixodidae
B. garinii I. ricinus Ixodidae
I. uriae Ixodidae
I. hexagonus Ixodidae
I. trianguliceps Ixodidae
I. persulcatus Ixodidae
Haemaphysalis longicornis Ixodidae
Human Anaplasmosis Anaplasma phagocytophilum I. scapularis Ixodidae
I. pacificus Ixodidae
Human Babesiosis Babesia microti I. scapularis Ixodidae
Tularemia Francisella tularensis I. dentatus Ixodidae
I. ricinus Ixodidae
Dermacentor variabilis Ixodidae
D. andersoni Ixodidae
Amblyomma americanum Ixodidae
Q-fever Coxiella burnetii I. dentatus Ixodidae
I. trianguliceps Ixodidae
Rhipicephalus sanguineus Ixodidae
A. americanum Ixodidae
Japanese spotted fever Rickettsia japonica I. ovatus Ixodidae
D. taiwanensis Ixodidae
H. flava Ixodidae
Queensland tick typhus R. australis I. holocyclus Ixodidae
Tick-borne encephalitis Tick borne encephalitis virus I. ricinus Ixodidae
I. persulcatus Ixodidae
Boutonneuse fever R. conorii R. sanguineus Ixodidae
Ehrlichiosis Ehrlichia chaffeensis A. americanum Ixodidae
E. ewingii A. americanum Ixodidae
Rocky mountain spotted fever R. rickettsii A. canjennense Ixodidae
D. variabilis Ixodidae
D. andersoni Ixodidae
R. sanguineus Ixodidae
African tick-bite fever R. africae A. hebraeum Ixodidae
Siberian tick typhus R. sibirica D. nuttalli Ixodidae
Relapsing fever B. duttoni Ornithodoros moubata Argasidae
B. hermsii O. hermsi Argasidae
B. turicatae O. turicata Argasidae
African relapsing fever B. crocidurae O. erraticus sonrai Argasidae
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transmission from arthropods to mammalian hosts (Bill-
ingsley et al. 2008; Coutinho-Abreu and Ramalho-Ortigao
2010; Coutinho-Abreu et al. 2009; Oliveira et al. 2009;
Valenzuela 2004a). Several features are important to be
considered for the development of anti-vector vaccines for
humans (de la Fuente and Merino 2013; Merino et al. 2013).
First, candidate molecule should be critical for vector–
pathogen interaction. Disruption of the candidate molecule
by gene knock-out/down, RNA interference or antibody
blocking should affect acquisition or transmission or repli-
cation of pathogen inside vector. Second, the primary amino
acid sequence of the candidate molecule should be highly
conserved among different isolates of that species to facili-
tate development of unique antigen for vaccine design.
Third, candidatemolecule should provide high antibody titer
upon injection into humans to block pathogen transmission
from vectors. Fourth, candidate molecule should be com-
patible with different adjuvants to effectively induce
immune responses in humans. Lastly, candidate molecule
should not result in exaggerated immune responses leading
to immune-related disorders in humans.
The basic proposed strategy on the effect of anti-vector
vaccination in humans is illustrated in Fig. 1. For instance,
in the Northeastern part of the United States, Ixodes
scapularis ticks transmit Borrelia burgdorferi the causative
agent of Lyme disease, Anaplasma phagocytophilum the
agent of human anaplasmosis and Babesia microti the
agent of human Babesiosis (Table 1) (Anderson and
Magnarelli 2008). In nature, I. scapularis larval ticks get
infected with these pathogens upon feeding on infected
vertebrate hosts (Sonenshine and Roe 2014). Infected lar-
val ticks molt into nymphs. Humans accidently become
infected upon bite by an infected nymph carrying these
pathogens (Fig. 1). Three types of anti-vector vaccine
development strategies can be proposed to protect humans
from being infected. First, anti-vector vaccine can be
designed to degrade pathogens inside ticks that subse-
quently make ticks free of pathogens (Fig. 1). Second, anti-
vector vaccine can be developed against one of the vector
molecule to prevent transmission of pathogens to humans
(Fig. 1). Third, anti-vector vaccines can be designed to
degrade or affect physiology of ticks upon ingestion of a
blood meal. Collectively, these proposed strategies would
significantly improve development of potential therapeutic
targets to treat and/or control several of the human vector-
borne diseases.
Fig. 1 Anti-vector vaccines. Schematic representation of the pro-
posed strategy on the effect of anti-tick vaccination in humans is
shown. Larval ticks become infected by feeding on infected vertebrate
hosts and molt into nymphs. Nymphs transmit pathogens to humans.
Several scenarios might be envisioned with regard to the effect of anti-
tick vaccine administration in natural human population. Non-
vaccinated humans bitten by infected ticks may become infected and
develop disease symptoms or remain uninfected by natural resistance.
On the other hand, vaccinated individuals might be protected from
infection or may still become infected due to poor responsiveness to
the vaccine. As shown in the illustration, three types of vaccine
strategies can be considered. First, anti-vector vaccine can be designed
to degrade pathogens inside ticks. Second, anti-vector vaccine can be
designed to target vector molecules to prevent pathogen transmission.
Third, anti-vector vaccine can be designed to target vector molecules
to degrade or affect physiology and survival of ticks
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In this review, we focus on some of the important
findings in the field of anti-vector vaccines against wide
range of hard and soft ticks that include Ixodes, Haema-
physalis, Dermacentor, Amblyomma, Rhipicephalus and
Ornithodoros species. Due to our focus on providing a
‘‘snap shot’’ with certain level of subjectivity of including
studies from both hard and soft ticks, several of the other
important findings in this field are not included.
Anti-Ixodes Vaccine Candidates
Several of the studies have reported immunization of
animals with tick antigens to study the effect of vacci-
nation on pathogen transmission and acquisition. Active
immunization of mice with Salp15, a 15-kDa secreted
salivary gland protein from I. scapularis showed sub-
stantial protection (60 %) from tick-borne Borrelia (Dai
et al. 2009). Salp15 protein has several immunosuppres-
sive properties (Juncadella and Anguita 2009). It inhibits
CD4? T cell activation, complement activity and den-
dritic cell activation (Juncadella and Anguita 2009). B.
burgdorferi coats itself with Salp15 protein during exit
from ticks (Ramamoorthi et al. 2005). This coating pre-
vents evasion of immune responses against spirochetes
upon entry into the mammalian host (Ramamoorthi et al.
2005). Interaction of Salp15 with B. burgdorferi OspC is
critical during this process (Ramamoorthi et al. 2005).
Immunization of mice with Salp25D, a 25-kDa salivary
gland protein from I. scapularis reduced spirochete
acquisition by ticks to threefold in comparison to the non-
immunized controls (Narasimhan et al. 2007). Salp25D
has significant homology to peroxiredoxins antioxidants
that has been shown to play significant role in protecting
B. burgdorferi from reactive oxygen produced by neu-
trophils (Narasimhan et al. 2007). Blockade of gut-
specific protein TROSPA (tick receptor for outer surface
protein A) by TROSPA-antisera showed significant
reduction (75 %) of B. burgdorferi adherence to tick gut
in vivo that subsequently prevented colonization and
transmission of spirochete from ticks to mice (Pal et al.
2004). Interaction of TROSPA with B. burgdorferi Outer
surface protein A (OspA) is critical for colonization of
spirochetes in the gut (Pal et al. 2004). Mice immunized
with tick histamine release factor (tHRF) also showed
substantial reduction in spirochete transmission (Dai et al.
2010). Twenty to thirty percent of tHRF-immunized mice
were fully protected from spirochete transmission (Dai
et al. 2010). Recently, the tick salivary lectin pathway
inhibitor (TSLPI) from I. scapularis was shown to prevent
killing of B. burgdorferi from host complement system
(Schuijt et al. 2011). Mice vaccinated with TSLPI showed
30 % reduction in spirochete loads, but did not com-
pletely block transmission (Schuijt et al. 2011). Due to
lower percentage of protection of mice seen upon TSLPI
immunization, the authors in the study proposed a com-
bination vaccine therapy to prevent Lyme disease (Schuijt
et al. 2011). In Northeastern part of the United States, I.
scapularis ticks survive overwintering stages (Anderson
and Magnarelli 2008). Recently, we identified an anti-
freeze glycoprotein (IAFGP) molecule in I. scapularis
and I. ricinus ticks (Neelakanta et al. 2010). IAFGP is
found to be critical for the survival of ticks at cold tem-
peratures (Neelakanta et al. 2010). Interestingly, A.
phagocytophilum-infected ticks produced more IAFGP
and showed greater resistance to cold temperatures, sug-
gesting a symbiotic relationship of this microbe with its
vector host (Neelakanta et al. 2010). RNA interference of
IAFGP showed significant reduction of A. phagocytophi-
lum acquisition in ticks when fed on infected mice
(Neelakanta et al. 2010). These results clearly elucidate
the important role of IAFGP in ticks. Salp16, a 16-kDa
tick salivary gland protein, is shown to be critical for A.
phagocytophilum survival in ticks (Sukumaran et al.
2006). RNA interference (RNAi) of salp16 expression
showed significant (90 %) reduction of A. phagocytophi-
lum migration from gut to salivary glands (Sukumaran
et al. 2006). Our recent study showed that A. phagocy-
tophilum induces tick actin phosphorylation to selectively
regulate salp16 gene expression (Sultana et al. 2010). We
found substantial increase in G-actin content in tick
nuclear extracts upon A. phagocytophilum infection that
subsequently influenced salp16 gene expression (Sultana
et al. 2010). These results suggest important role of
Salp16 in tick-A. phagocytophilum interaction (Sultana
et al. 2010). Our study also demonstrated importance of I.
scapularis p21-activated kinase, PI3-kinase and G-pro-
teins in A. phagocytophilum survival in ticks (Sultana
et al. 2010). Study from Labuda et al. (2006) showed that
immunization of mice with 64TPR, a tick cement protein
protected mice from tick-borne encephalitis virus trans-
mission (Labuda et al. 2006). Viral titers were reduced to
more than 50 % in vaccinated mice in comparison to the
controls (Labuda et al. 2006). 64TPR is a 15-KDa protein
that express at higher levels during tick feeding (Labuda
et al. 2006). Moreover, 64TPR has been shown as a broad-
spectrum vaccine candidate against several tick species
(Labuda et al. 2006).
Homologues of Salp15 have been identified in I. pac-
ificus, I. persulcatus and I. sinensis that transmit Borrelia
(Table 1) in Western North America and Asia (Hojgaard
et al. 2009; Wang et al. 2014b). Three Salp15 homologues
were identified in I. ricinus, where one of the predicted
protein showed 80 % and two other proteins showed 60 %
similarity with I. scapularis Salp15 (Hovius et al. 2007).
Recent study has identified 5 and 3 Salp15-like proteins in
I. persulcatus and I. sinensis ticks, respectively (Wang
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et al. 2014b). Intraspecies and interspecies comparison of
these proteins with other Salp15 proteins revealed equal
degree of similarity (Wang et al. 2014b). High degree of
similarity was evident in the 53-amino acid stretches at
the C-terminus of the protein (Hojgaard et al. 2009).
These studies have demonstrated that Salp15 and Salp15-
like proteins are distributed in three clades and represent a
multigene family (Hojgaard et al. 2009; Hovius et al.
2007; Wang et al. 2014b). Homologues of Salp16 have
been identified in I. persulcatus Schulze ticks (Hidano
et al. 2014). These proteins were designated as Salp16
Iper1 and Iper2 (Hidano et al. 2014). I. persulcatus Salp16
proteins have been shown to attenuate oxidative burst of
the bovine neutrophils and inhibited migration induced by
chemoattractant interleukin-8 (Hidano et al. 2014). This
study provides important information on the role of
Salp16 in tick blood feeding and as immunosuppressant of
neutrophils (Hidano et al. 2014). Homologues of TRO-
SPA have been identified in I. ricinus and I. persulcatus
ticks (Konnai et al. 2012). I. persulcatus TROSPA was
found to be 88.2 and 87.8 % identical to I. scapularis and
I. ricinus TROSPA, respectively (Figlerowicz et al. 2013;
Konnai et al. 2012). Figlerowicz et al. (2013) showed that
I. ricinus recombinant TROSPA retained capacity of
native protein to form a complex with OspA and induced
significant level of IgG in orally immunized animals
(Figlerowicz et al. 2013). Recent study has used Ana-
plasma and Babesia infection model to characterize
Subolesin (SUB), SILK and TROSPA as potential anti-
gens to control cattle tick infestations (Antunes et al.
2014). Rabbit polyclonal antibodies generated against
SUB, SILK and TROSPA were added to uninfected or
infected bovine blood to capillary feed Rhipicephalus
microplus ticks (Antunes et al. 2014). Even though results
from capillary feeding showed substantial effect on tick
weight and oviposition, pathogen levels were unaltered in
ticks treated with these antibodies in comparison to the
control ticks (Antunes et al. 2014). Due to tick-to-tick
variations, this study concluded that capillary feeding was
not an ideal technique to characterize efficacy of a vac-
cine candidate (Antunes et al. 2014). Recent study
analyzed whether adaptive evolution has shaped the
Salp15 protein family (Schwalie and Schultz 2009). Evi-
dence was seen at several positions within the Salp15
protein family showing phases of positive selection
(Schwalie and Schultz 2009). It would be interesting to
determine whether the set of several conserved proteins
that function in tick–pathogen interactions is also under
positive selection. Like Salp15, if Salp16, TROSPA and
SUB are also under positive selection, it might be inter-
esting to characterize whether these proteins play
differential roles in the interactions with various patho-
gens (Table 1).
Anti-Haemaphysalis Vaccine Candidates
Some of the Haemaphysalis species transmit pathogens to
humans that cause diseases like Lyme borreliosis and
spotted fever (Table 1). Study from Chai et al. (2009) has
identified 12 unique cDNA sequences in a phage library
that encode putative immunodominant antigens in Hae-
maphysalis longicornis. Harnnoi et al. (2006) have
identified genes encoding cement-like antigens in H. lon-
gicornis. These cement-like proteins in H. longicornis were
upregulated upon feeding (Harnnoi et al. 2006). HISP, a
cubilin-related serine proteinase was identified in H. lon-
gicornis (Miyoshi et al. 2004). HISP expression was highly
upregulated during tick feeding indicating its role in
digestion of host blood components (Miyoshi et al. 2004).
Recent study characterized acid phosphatase from H. lon-
gicornis (Zhang et al. 2011). Rabbits vaccinated with
recombinant acid phosphatase conferred protective immu-
nity, resulting in 28 % mortality and 10.6 % reduction in
body weight of adult ticks (Zhang et al. 2011). Scavenger
receptors are predominantly expressed by mammalian
macrophages and are shown to be important in innate
immunity (Aung et al. 2011). Study from Aung et al.
(2011) have identified Scavenger receptor homologue
(HISRB) in H. longicornis for the first time in Chelicerata
that include ticks, horseshoe crabs, scorpions, spiders and
mites. Silencing of HISRB gene resulted in reduced tick
body weight (Aung et al. 2011). It is not surprising to
hypothesize that HISRB can be considered as an effective
candidate for the development of vaccine against H. lon-
gicornis (Aung et al. 2011). Follistatin-related protein
(Zhou et al. 2006a) and Valosin-containing protein
(Boldbaatar et al. 2007) have been identified in H. longi-
cornis that are critical for tick oviposition and
engorgement. A salivary gland protein Longistatin, a serine
protease with two EF-domains has been recently identified
in H. longicornis (Anisuzzaman et al. 2012). The study
showed that Longistatin hydrolyzed fibrinogen and acti-
vated plasminogen into its active form plasmin
(Anisuzzaman et al. 2012). Immunization of Longistatin in
animals produced high IgG titers against ticks that revealed
54 % tick repletion, and reduction of tick body weight to
11 % in comparison to controls (Anisuzzaman et al. 2012).
Zhou et al. (2006b) cloned and characterized Cystatin gene
from H. longicornis. Their study revealed that recombinant
Cystatin protein showed growth-inhibitory effect on
Babesia bovis cultured in vitro. The authors indicated that
Cystatin is critical for tick immunity (Zhou et al. 2006b).
Anti-Dermacentor Vaccine Candidates
Several species of Dermacentor ticks are known carriers of
many human pathogens (Table 1). Subolesin, an ortholog
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of insect akirins is a highly conserved protein that could be
potentially considered as vaccine against various blood
sucking vectors including ticks and mosquitoes (de la Fu-
ente et al. 2011). Hu et al. (2014) have cloned,
characterized and analyzed immunogenicity of D. silvarum
SUB. Their analysis showed that anti-D. silvarum serum
recognized recombinant SUB, suggesting an host immune
response against this protein (Hu et al. 2014). Fibrinogen-
related proteins are shown to be important for tick innate
system and are suggested to be potential candidates for the
development of anti-tick vaccines (Hajdusek et al. 2013).
Recent study has identified fibrinogen-related proteins from
D. marginatus, Rhipicephalus appendiculatus, R. pulchel-
lus and R. sanguineus (Sterba et al. 2011). Dermacentor
ticks feed for 6–10 days with varying expression levels of
several tick proteins involved in the process of blood
feeding (Sonenshine and Roe 2014). Salivary gland
extracts isolated at different times during D. andersoni
feeding showed esterase activities (Gordon and Allen
1987). Another study determined immunogenic proteins in
R. sanguineus and D. reticulatus ticks using 2-D gel
electrophoresis (Vu Hai et al. 2013). IgG response against
bite of R. sanguineus and D. reticulatus ticks were deter-
mined in rabbits (Vu Hai et al. 2013). Using antiserum
from rabbits exposed to these two ticks, important candi-
date antigens for the development of anti-tick vaccines
were identified (Vu Hai et al. 2013). These include but are
not limited to heme-binding, cement and Vitellogenin-2
proteins from R. sanguineus and hemelipoglycoprotein
precursor, Serpin-2 precursor, Calreticulin from D. retic-
ulatus (Vu Hai et al. 2013). The major hemelipoglyco-
carrier protein (CP) was identified from D. variabilis
(Donohue et al. 2008). Expression and domain structure of
CP matched Vitellogenin that suggested its role in heme
sequestration, evolution of hematophagy and host com-
plementation (Donohue et al. 2008). Anderson et al. (2008)
explored D. variabilis mialome of ticks and identified 82
transcripts that encode proteins putatively associated in
blood meal digestion, enzymes involved in oxidative stress,
peptidase inhibitors, protein digestion, protein and lipid
binding, mucins and iron/heme metabolism. Transcripts
encoding lectin- and allergen-like proteins were also
identified in that screen (Anderson et al. 2008). Studies like
these would provide evidences on the role of several pro-
teins in blood digestion, antimicrobial activity and
transmission of pathogens that could be envisioned for the
development of anti-Dermacentor vaccines.
Anti-Amblyomma Vaccine Candidates
Amblyomma ticks are vectors for several Rickettsia spp.
and Francisella tularensis that cause diseases in humans
(Table 1). Mulenga et al. (2013b) have identified tick
feeding stimuli responsive gene AamAV422 gene that
belong to a novel group of arthropod proteins. AamAV422
contain 14 cysteine amino acid residues that are predicted
to form seven disulfide bonds (Mulenga et al. 2013b).
AamAV422 has been suggested to mediate tick anti-
hemostasis and anti-complement activity (Mulenga et al.
2013b). RNA interference against AamAV422 caused
significant (44 %) reduction in tick engorgement weights
(Mulenga et al. 2013b). This study concluded that Aa-
mAV422 could be considered as a potential candidate for a
cocktail or multivalent tick vaccine (Mulenga et al. 2013b).
A. americanum saliva cysteine proteases have been shown
to delay plasma clotting and inhibit platelet aggregation
(Mulenga et al. 2013a). Three of the insulin-like growth
factor binding proteins (IGFBP) has been identified in A.
americanum (Mulenga and Khumthong 2010b). Silencing
of the IGFBPs had substantial effect on tick feeding
(Mulenga and Khumthong 2010b). Organic anion Na?-
independent transporting polypeptide (AamOatp) that
function in wide range of endogenous and xenobiotic
compounds transport across plasma membrane has been
identified in A. americanum (Mulenga et al. 2008).
Silencing of AamOatp showed significant reduction in
blood intake by ticks (Mulenga et al. 2008). Recently tick
CD147 receptor was identified and characterized in A.
americanum (Mulenga and Khumthong 2010a). CD147
receptors are cell-surface glycoprotein in IgG family that
play an important role in extracellular matrix remodeling
(Huet et al. 2008). The expression of A. americanum
CD147 receptor was found to be up regulated upon tick
feeding in salivary glands, but remain unaltered in gut
suggesting differential roles in these tissues (Mulenga and
Khumthong 2010a). The authors of this research study
showed that CD147 receptor silencing abrogates tick inter-
molt growth (Mulenga and Khumthong 2010a). Study from
de la Fuente et al. (2010) have used four cDNA clones
encoding putative threonyl-tRNA synthetase (2C9), 60S
ribosomal proteins L13a (2D10) and L13e (2B7) and
interphase cytoplasm foci protein 45 (2G7) for immuni-
zation studies in cattle. Immunization with 2G7 showed
significant (E[ 55 %) control of adult ticks (de la Fuente
et al. 2010). Immunization with 2D10, 2G7 and subolesin
affected control of both nymphs and adults (de la Fuente
et al. 2010).
Anti-Rhipicephalus Vaccine Candidates
Rhipicephalus ticks transmit pathogens that cause diseases
in humans (Table 1). Study from Rodriguez-Mallon
focused on Rhipicephalus ribosomal proteins (Rodriguez-
Mallon et al. 2012) identified a unique immunogenic region
of protein P0. This protein is important in the assembly of
60S ribosomal subunit (Rodriguez-Mallon et al. 2012). The
174 Arch. Immunol. Ther. Exp. (2015) 63:169–179
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immunogenic region of Rhipicephalus species is not con-
served in comparison to host P0 protein (Rodriguez-Mallon
et al. 2012). Animals were challenged with peptide gen-
erated based on the sequence from non-conserved region
(Rodriguez-Mallon et al. 2012). The results showed that
when larvae were fed on vaccinated animals, significant
reduction of viability of newly molted R. sanguineus
nymphs were noted (Rodriguez-Mallon et al. 2012). More
than 90 % reduction was observed in tick egg hatching
(Rodriguez-Mallon et al. 2012). Overall, their study pro-
vided evidence that vaccination of animals with P0
significantly reduced survival of ticks. R. microplus gut
cells express Bm86, a membrane-bound glycoprotein on
the surface (De La Fuente et al. 2000; Willadsen et al.
1989; Willadsen and Jongejan 1999). Even though the
unknown biological function of Bm86 in ticks is yet to be
explored, several studies have used Bm86 as a protective
antigen against protection from infestation of cattle ticks R.
microplus and R. annulatus (Carreon et al. 2012; de la
Fuente et al. 1999; De La Fuente et al. 2000; Rodriguez-
Mallon et al. 2012; Rodriguez-Valle et al. 2012; Willadsen
and Jongejan 1999; Willadsen et al. 1989, 1996). Protec-
tion of Cattle from R. microplus infestations by Bm86
vaccination was achieved due to the generation of antigen-
specific antibodies by the host that subsequently affected
tick infestations and fertility (Willadsen and Jongejan
1999; Willadsen et al. 1989, 1996). Bm86-based Tick-
GARD and Gavac vaccines are now commercially
available anti-vector vaccines for animals (Odongo et al.
2007; Valle et al. 2004; Willadsen et al. 1995). Perez-Perez
and co-authors vaccinated domestic dogs with Bm86 and
infested them with three instars of R. sanguineus (Perez-
Perez et al. 2010). Their study revealed that ticks fed on
vaccinated animals had reduced viability in comparison to
controls. R. sanguineus was used to evaluate silencing
effects of tick protective antigens 4D8 and Rs86, homo-
logues of Bm86 (de la Fuente et al. 2006). Silencing of 4D8
alone had effect on tick feeding, attachment and oviposi-
tion (de la Fuente et al. 2006). Silencing of Rs86 had an
effect on tick weight and oviposition (de la Fuente et al.
2006). Combined silencing of expression of both genes
(4D8 and Rs86) had significant effect on R. sanguineus
survival, attachment, feeding, weight and oviposition (de la
Fuente et al. 2006). The authors from this study proposed
the development of multi-antigenic vaccines to prevent
infestation from R. sanguineus (de la Fuente et al. 2006).
This type of multi-antigenic vaccine comprising Vitellin-
degrading cysteine endopeptidase and Boophilus yolk pro-
cathepsin both from R. microplus and glutathione S-trans-
ferase from H. longicornis was evaluated against the cattle
tick R. microplus (Parizi et al. 2012). Increased antibody
titers were evident in vaccinated animals (Parizi et al.
2012). The multi-antigenic vaccine administration in
animals had substantial effect on tick infestations, where
significantly lower numbers of semi-engorged female ticks
were noted (Parizi et al. 2012). Vaccination with truncated
construct of cement protein (64TRPs) derived from R.
appendiculatus showed significant cross protection against
R. sanguineus (Trimnell et al. 2005). Recently, three major
glycoproteins (GLPs) of sizes about 90, 66 and 40 kDa
have been purified from adult and larval Hyalomma
dromedarii (camel ticks) (El Hakim et al. 2011). Immu-
nization with GLPs protected animals from H. dromedarii
infestations (El Hakim et al. 2011). Immune sera raised
against H. dromedarii GLPs were able to recognize pro-
teins from R. sanguineus, suggesting its efficacy as a potent
vaccine candidate against other ticks species (El Hakim
et al. 2011). Sialotranscriptome of R. sanguineus has now
been determined that could aid in the additional discovery
of candidate molecules important for the development of
anti-Rhipicephalus vaccines (Anatriello et al. 2010).
Anti-Ornithodoros Vaccine Candidates
Ornithodoros tick species are important vectors for the
transmission of relapsing fever spirochetes (Table 1). As-
tigarraga et al. (1995) performed a study by immunizing
animals with concealed antigens or salivary gland extracts
from O. erraticus. While immunization with concealed
antigens did not result in any protection against ticks,
immunization with salivary gland extracts significantly
reduced blood ingestion (40–60 %) and fecundity
(40–60 %) in ticks (Astigarraga et al. 1995). This was also
evident in immunization with salivary gland extracts pre-
pared from O. moubata (Astigarraga et al. 1995). Factor Xa
inhibitor (fXaI; anti-coagulation factor) has been identified
in O. savignyi that shows 46 % identity and 78 % simi-
larity in amino acid sequence with fXaI from O. moubata
(Joubert et al. 1998). Midgut membrane extracts prepared
from O. erraticus were administered to mice and pigs to
test protective responses in these animals against ticks
(Manzano-Roman et al. 2006). When midgut extracts were
injected with Freund’s adjuvants into these animals, 80 %
of the immature forms of the ticks were killed in the first
72 h post-feeding and also decreased fecundity in females
by more than 50 % (Manzano-Roman et al. 2006). The
significant rate of killing was attributed to the damage of
midgut wall of ticks (Manzano-Roman et al. 2006). It was
also noted that some proteins present in the midgut extracts
were expressed in all developmental stages of O. erraticus
ticks and found to be induced upon feeding suggesting
important targets for the vaccine development (Manzano-
Roman et al. 2006). Subolesin orthologs were identified in
O. erraticus and O. moubata ticks (Manzano-Roman et al.
2012b). The Subolesin of both these ticks show more than
69 and 74 % identify with Subolesin from hard ticks in
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their nucleotide and amino acid sequences, respectively
(Manzano-Roman et al. 2012b). RNAi-mediated silencing
of Subolesin inhibited Ornithodoros oviposition indicating
importance of this protein in tick oviposition (Manzano-
Roman et al. 2012b). Immunization studies with soft tick
recombinant Subolesin induced partial protective effect
resulting in reduced oviposition rates of these ticks
(Manzano-Roman et al. 2012b). A lectin, designated as
Dorin M, with high hemagglutinating activity was isolated
from O. moubata (Kovar et al. 2000). This was a first report
of purified lectin from ticks (Kovar et al. 2000). Significant
levels of enolase have been found in the saliva of O.
moubata ticks (Diaz-Martin et al. 2013). Enolase is a
glycolytic enzyme that acts as plasminogen receptor on cell
surface to promote fibrinolysis and extracellular matrix
degradation (Diaz-Martin et al. 2013). The function of
enolase could be important for ticks to digest clots and also
to prevent clotting formed during feeding (Diaz-Martin
et al. 2013). RNAi and immunization studies revealed that
O. moubata enolase could be involved in tick reproduction
(Diaz-Martin et al. 2013). Using self-assembled protein
arrays, a recent study has identified important tick mole-
cules in the O. moubata salivary gland expression library
(Manzano-Roman et al. 2012a). Several clones that bind to
human P-selectin were identified in the screen (Manzano-
Roman et al. 2012a). Secreted tick phospholipase A2,
which could function as potential new ligand for P-selectin
was also identified (Manzano-Roman et al. 2012a). This
strategy provides one of the important breakthroughs in the
identification of several vaccine candidates in ticks
(Manzano-Roman et al. 2012a). Cystatin from O. moubata
has been identified (Salat et al. 2010). Immunization
studies with recombinant Cystatin (OmC2) significantly
suppressed survival of O. moubata (Salat et al. 2010). A
tick salivary gland glycoprotein of 44 kDa (Om44) that
carries heparin determinant has been identified in O.
moubata salivary gland extracts (Garcia-Varas et al. 2010).
Partial characterization of this protein revealed that Om44
binds host P-selectin, that presumably prevents the adhe-
sion of leucocytes and platelets to vessel walls (Garcia-
Varas et al. 2010). Om44 cannot be recognized by host
immune system, but can be neutralized by antibodies. This
study found significant inhibition of O. moubata feeding on
vaccinated animals in comparison to the controls, making
new prospects in the development of anti-O. moubata and
perhaps other Ornithodoros species vaccine (Garcia-Varas
et al. 2010).
Conclusions
In this review, we provide an overview of potential can-
didates for the development of anti-vector vaccines against
human diseases transmitted by various hard and soft ticks.
Several commercial and technical challenges need to be
overcome in order to develop an effective anti-vector
vaccine for human use (de la Fuente et al. 2007; Merino
et al. 2013). Some of the challenges to overcome are: (1)
limitation in the molecular evidences to understand how
anti-vector vaccine works in humans; (2) overall ineffec-
tiveness of anti-vector vaccines to control certain tick
population (De La Fuente et al. 2000; de Vos et al. 2001);
(3) limited interest for commercialization and vaccine
production on large scale and (4) insufficient knowledge
dispersal to the public about the use of anti-vector
vaccines.
Over the past decade, several studies have used
genomics, transcriptomics and proteomics approaches to
identify some of the potential candidates for the develop-
ment of anti-vector vaccines (Dinglasan et al. 2005; Geiger
et al. 2011; Gibson et al. 2013; Heekin et al. 2013a, b; Hill
et al. 2005; Patramool et al. 2012; Ramabu et al. 2010;
Schwarz et al. 2013; Valenzuela 2004b; Vernick and
Waters 2004; Villar et al. 2014a, b). With the availability
of already abundant amount of information on several tick
genomes, transcriptomes and proteomes, future studies
need to focus on developing suitable animal models and
approaches to evaluate proper efficacy of a molecule as a
vaccine candidate for human trials. Studies using multi-
disciplinary approaches such as use of bioinformatic
analysis for epitope prediction, protein folding and post-
translational modifications on a vaccine candidate mole-
cule would strengthen development of anti-vector vaccines.
In addition, development of multivalent-vaccine formula-
tions comprising vaccines targeting both vector and
pathogen would provide a significant leap in this research
area to move forward from bench-to-bedside.
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